Last reviewed · How we verify

NCT05108363

Effect of Obstructive Sleep Apnea on Glucose Control and Cognitive Function

Withdrawn NA Last updated 20 February 2024
What this trial tests

NA trial testing Lifestyle modification program in Cognitive Change. Withdrawn.

Timeline
1 November 2021
Primary endpoint
31 May 2023
30 November 2023

Quick facts

Lead sponsorChinese University of Hong Kong
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Start date1 November 2021
Primary completion31 May 2023
Estimated completion30 November 2023
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Chinese University of Hong Kong

Who can join

Adults 40 to 65, any sex, with Cognitive Change. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Obstructive sleep apnea (OSA) may contribute to altered cognitive function in patients suffering from severe OSA. And lifestyle modification program may improve the cognitive function after 6 months of therapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Lifestyle modification program

Trials testing the same drug.

Other recruiting trials for Cognitive Change

Currently open trials in the same condition.

Other Chinese University of Hong Kong trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05108363.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing